India
· Delayed Price · Currency is INR Tatva Chintan Pharma Chem Statistics
Total Valuation
NSE:TATVA has a market cap or net worth of INR 16.93 billion. The enterprise value is 16.93 billion.
| Market Cap | 16.93B |
| Enterprise Value | 16.93B |
Important Dates
The next estimated earnings date is Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | Sep 6, 2024 |
Share Statistics
NSE:TATVA has 23.39 million shares outstanding. The number of shares has increased by 3.70% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 23.39M |
| Shares Change (YoY) | +3.70% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 72.02% |
| Owned by Institutions (%) | 13.77% |
| Float | 6.55M |
Valuation Ratios
The trailing PE ratio is 118.52 and the forward PE ratio is 43.87. NSE:TATVA's PEG ratio is 1.77.
| PE Ratio | 118.52 |
| Forward PE | 43.87 |
| PS Ratio | 4.54 |
| PB Ratio | 2.29 |
| P/TBV Ratio | 2.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.77 |
Enterprise Valuation
| EV / Earnings | 118.41 |
| EV / Sales | 4.54 |
| EV / EBITDA | 31.82 |
| EV / EBIT | 107.03 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | n/a |
| Interest Coverage | 21.49 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 1.28% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 5.42M |
| Profits Per Employee | 207,504 |
| Employee Count | 689 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.58% in the last 52 weeks. The beta is 0.04, so NSE:TATVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -41.58% |
| 50-Day Moving Average | 699.38 |
| 200-Day Moving Average | 868.87 |
| Relative Strength Index (RSI) | 50.90 |
| Average Volume (20 Days) | 30,277 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:TATVA had revenue of INR 3.73 billion and earned 142.97 million in profits. Earnings per share was 6.11.
| Revenue | 3.73B |
| Gross Profit | 1.82B |
| Operating Income | 158.17M |
| Pretax Income | 192.43M |
| Net Income | 142.97M |
| EBITDA | 529.61M |
| EBIT | 158.17M |
| Earnings Per Share (EPS) | 6.11 |
Balance Sheet
The company has 148.73 million in cash and 152.31 million in debt, giving a net cash position of -3.58 million or -0.15 per share.
| Cash & Cash Equivalents | 148.73M |
| Total Debt | 152.31M |
| Net Cash | -3.58M |
| Net Cash Per Share | -0.15 |
| Equity (Book Value) | 7.38B |
| Book Value Per Share | 322.15 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 48.66%, with operating and profit margins of 4.24% and 3.83%.
| Gross Margin | 48.66% |
| Operating Margin | 4.24% |
| Pretax Margin | 5.16% |
| Profit Margin | 3.83% |
| EBITDA Margin | 14.19% |
| EBIT Margin | 4.24% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.28%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.28% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.70% |
| Shareholder Yield | -3.42% |
| Earnings Yield | 0.84% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |